4569.T
KYORIN Pharmaceutical Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,167.00
−1.35%Year over year
Reported trailing growth
- Revenue
- -2.9%
- EBITDA
- —
- EBIT
- -71.6%
- EPS
- -62.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.6%
- EBITDA
- —
- EPS
- +39.2%
Three-year CAGR
- Revenue
- +3.7%
- EBITDA
- -2.8%
- EBIT
- -11.4%
- Net income
- -10.0%
- EPS
- -10.0%
- Free cash flow
- +214.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026